AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24661511 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy combined with Saccharomyces boulardii (250 mg, Bid)
Number of subjects: 240
Study 23171757 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated PCV2 vaccine
Number of subjects: 10
Study 23171757 — intervention group
Group type: COMPARATOR
Intervention: Sterile PBS (control)
Number of subjects: 10
Study 20601905 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and prebiotic fortified milk (1.9 x 10 colony-forming units of Bifidobacterium lactis HN019 and 2.4 g/day of prebiotic oligosaccharides)
Number of subjects: 624
Study 20601905 — intervention group
Group type: COMPARATOR
Intervention: Control milk (non-fortified)
Number of subjects: 624
Study 17568755 — intervention group
Group type: EXPERIMENTAL
Intervention: ETCare
Number of subjects: 60
Study 17568755 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 60
Study 15702140 — intervention group
Group type: EXPERIMENTAL
Intervention: TYR-free amino acid drink (74 g, lacking TYR and PHE)
Number of subjects: 15
Study 15702140 — intervention group
Group type: COMPARATOR
Intervention: Balanced amino acid drink (BAL)
Number of subjects: 15
Study 12093460 — intervention group
Group type: EXPERIMENTAL
Intervention: 19.6 g of arginine/d for 14 days (n = 6)
Number of subjects: 11
Study 12093460 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 days (n = 5)
Number of subjects: 11
Study 11225649 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin-bound chromium 200 microg t.i.d. for 2 months
Number of subjects: 20
Study 11225649 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d. for 2 months
Number of subjects: 20
Study 11225649 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin-bound chromium 600 microg daily for 2 months
Number of subjects: 20
Study 7586602 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose group (131I dose based on thyroid gland type, accurate volume measurement, and 24-hour uptake determination)
Number of subjects: 163
Study 7586602 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose group (fixed doses of 185, 370, or 555 MBq based on gland size assessment by palpation)
Number of subjects: 163
Study 1778089 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenothrin liquid shampoo
Number of subjects: 50
Study 1778089 — intervention group
Group type: COMPARATOR
Intervention: Carbaryl lotion
Number of subjects: 50
Study 6118066 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiparkinsonian group
Number of subjects: 32
Study 6118066 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 32
Study 31434848 — intervention group
Group type: COMPARATOR
Intervention: 22-gauge conventional non-fenestrated catheter
Number of subjects: 50
Study 31434848 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-gauge fenestrated catheter
Number of subjects: 50
Study 31434848 — intervention group
Group type: COMPARATOR
Intervention: 22-gauge non-fenestrated catheter
Number of subjects: 50
Study 30004570 — intervention group
Group type: EXPERIMENTAL
Intervention: PFNA treatment
Number of subjects: 80
Study 30004570 — intervention group
Group type: COMPARATOR
Intervention: DHS internal fixation
Number of subjects: 80
Study 26879224 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for healthy groceries ($1 for every healthy food or beverage purchased)
Number of subjects: 54
Study 26879224 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 54
Study 26879224 — intervention group
Group type: COMPARATOR
Intervention: Frequent coupon users (FCU)
Number of subjects: 54
Study 26879224 — intervention group
Group type: COMPARATOR
Intervention: Non-coupon users (NCU)
Number of subjects: 54
Study 24837298 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxy measures (care home staff reporting)
Number of subjects: 565
Study 22517930 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip resurfacing arthroplasty
Number of subjects: 126
Study 22517930 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty
Number of subjects: 126
Study 19686276 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% octenidine with 30% 1-propanol and 45% 2-propanol
Number of subjects: 400
Study 19686276 — intervention group
Group type: COMPARATOR
Intervention: 74% ethanol with 10% 2-propanol
Number of subjects: 400
Study 18035199 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine 225 mg BID and chest physiotherapy
Number of subjects: 30
Study 18035199 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy alone
Number of subjects: 30
Study 16060740 — intervention group
Group type: EXPERIMENTAL
Intervention: High impression management individuals (Study 1)
Number of subjects: 4
Study 16060740 — intervention group
Group type: EXPERIMENTAL
Intervention: High impression management individuals (Study 2)
Number of subjects: 4
Study 16060740 — intervention group
Group type: EXPERIMENTAL
Intervention: High impression management African Americans (Study 3)
Number of subjects: 4
Study 16060740 — intervention group
Group type: EXPERIMENTAL
Intervention: High impression management White students (Study 4)
Number of subjects: 4
Study 12212411 — intervention group
Group type: EXPERIMENTAL
Intervention: Theater production 'All's Well That Eats Well'
Number of subjects: 4093
Study 10490784 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet for 2-5 weeks
Number of subjects: 10
Study 10490784 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet after substantial weight loss
Number of subjects: 10
Study 10490784 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet (early stages of weight loss)
Number of subjects: 10
Study 10490784 — intervention group
Group type: EXPERIMENTAL
Intervention: Post substantial weight loss
Number of subjects: 10
Study 7808487 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Number of subjects: 623
Study 7808487 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 623
Study 7808487 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy
Number of subjects: 623
Study 7808487 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (both types)
Number of subjects: 623
Study 1657501 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilt (60 degrees) in subjects with age-related orthostatic hypotension
Number of subjects: 28
Study 1657501 — intervention group
Group type: COMPARATOR
Intervention: Head-up tilt (60 degrees) in healthy elderly control subjects
Number of subjects: 28
Study 1657501 — intervention group
Group type: COMPARATOR
Intervention: Cold stress and sustained isometric exercise in both groups
Number of subjects: 28
Study 1657501 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilt in subjects with autonomic neuropathy
Number of subjects: 28
Study 1657501 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma concentrations of noradrenaline, adrenaline, and neuropeptide-Y-like immunoreactivity after head-up tilt
Number of subjects: 28
Study 1657501 — intervention group
Group type: EXPERIMENTAL
Intervention: Aorto-iliac pulse wave velocity index in subjects with age-associated orthostatic hypotension
Number of subjects: 28
Study 7048929 — intervention group
Group type: EXPERIMENTAL
Intervention: Long course of ampicillin (3 days)
Number of subjects: 0
Study 7048929 — intervention group
Group type: COMPARATOR
Intervention: Short course of ampicillin (three doses)
Number of subjects: 0
Study 7048929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29553432 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (20% intravenous propofol for induction, atracurium for muscle relaxation, nitrous oxide and oxygen for maintenance)
Number of subjects: 181
Study 29553432 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia (0.5% hyperbaric solution bupivacaine with 20 μg fentanyl intrathecally)
Number of subjects: 181
Study 29553432 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 181
Study 29553432 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia
Number of subjects: 181
Study 27814862 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates group (PG)
Number of subjects: 31
Study 27814862 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise group (TG)
Number of subjects: 31
Study 24235775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent maximal lactate steady state (MLSSint = 15.26 ± 0.97 km/h)
Number of subjects: 10
Study 24235775 — intervention group
Group type: COMPARATOR
Intervention: Continuous maximal lactate steady state (MLSScon = 14.53 ± 0.93 km/h)
Number of subjects: 10
Study 22699241 — intervention group
Group type: EXPERIMENTAL
Intervention: Early skin-to-skin contact (SSC)
Number of subjects: 41
Study 22699241 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control)
Number of subjects: 41
Study 20175608 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural Ecosystems Therapy (SET)
Number of subjects: 156
Study 20175608 — intervention group
Group type: COMPARATOR
Intervention: Person-centered therapy
Number of subjects: 156
Study 20175608 — intervention group
Group type: COMPARATOR
Intervention: Community control condition
Number of subjects: 156
Study 17683868 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 0
Study 17683868 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective EPO analogues
Number of subjects: 0
Study 16304166 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (oral and intravenous doses)
Number of subjects: 12
Study 11807960 — intervention group
Group type: EXPERIMENTAL
Intervention: Kava (n = 18) for 7 days
Number of subjects: 54
Study 11807960 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian (n = 18) for 7 days
Number of subjects: 54
Study 11807960 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 18)
Number of subjects: 54
Study 9684421 — intervention group
Group type: EXPERIMENTAL
Intervention: n-of-1 trial
Number of subjects: 0
Study 8075030 — intervention group
Group type: EXPERIMENTAL
Intervention: Oophorectomy (or ovarian ablation)
Number of subjects: 85
Study 8075030 — intervention group
Group type: EXPERIMENTAL
Intervention: Oophorectomy plus tamoxifen
Number of subjects: 85
Study 8075030 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 85
Study 8075030 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin plus tamoxifen
Number of subjects: 85
Study 8075030 — intervention group
Group type: COMPARATOR
Intervention: Oophorectomy (or ovarian irradiation)
Number of subjects: 85
Study 2802118 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion (3.93 mg/kg)
Number of subjects: 12
Study 2802118 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.28 mg/kg)
Number of subjects: 12
Study 2802118 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 12
Study 2802118 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 12
Study 4404939 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g ampicillin daily
Number of subjects: 126
Study 4404939 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g ampicillin daily
Number of subjects: 126
Study 4404939 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g ampicillin daily + 20 mg prednisolone daily
Number of subjects: 126
Study 4404939 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g ampicillin daily + 20 mg prednisolone daily
Number of subjects: 126
Study 4404939 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 126
Study 31221534 — intervention group
Group type: EXPERIMENTAL
Intervention: Hp2‐2 phenotype
Number of subjects: 1256
Study 31221534 — intervention group
Group type: COMPARATOR
Intervention: Hp1‐1 and Hp1‐2 phenotypes
Number of subjects: 1256
Study 31445962 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study 31445962 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study 27158908 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 5 mg/Kg/day for 60 days (n = 47)
Number of subjects: 111
Study 27158908 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 5 mg/Kg/day open-label (n = 16)
Number of subjects: 111
Study 27158908 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 48)
Number of subjects: 111
Study 27158908 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole treatment
Number of subjects: 111
Study 24602553 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 35
Study 24602553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 22429273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive administered 30 minutes after exenatide
Number of subjects: 32
Study 22429273 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated daily oral contraceptive administration 30 minutes after exenatide
Number of subjects: 32
Study 22429273 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive administered 1 hour before exenatide
Number of subjects: 32
Study 21246844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (Shenmen (HT 7), Baihui (CV 20), Hegu (LI 4), Taichong (LR 3))
Number of subjects: 65
Study 21246844 — intervention group
Group type: COMPARATOR
Intervention: Trazodone (oral administration for 4 weeks)
Number of subjects: 65
Study 21246844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 65
Study 18979978 — intervention group
Group type: EXPERIMENTAL
Intervention: FV intervention
Number of subjects: 20
Study 18979978 — intervention group
Group type: COMPARATOR
Intervention: Smoking cessation intervention
Number of subjects: 20
Study 16389212 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based antismoking socialization program (n = 371) including 5 printed activity guides, parenting tip sheets, child newsletters, and incentives, plus a booster activity guide 1 year later.
Number of subjects: 776
Study 16389212 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 405) received fact sheets about smoking.
Number of subjects: 776
Study 16389212 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 405)
Number of subjects: 776
Study 14598513 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 14598513 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 0
Study 14598513 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (NMDA receptor antagonist)
Number of subjects: 0
Study 14598513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14598513 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of naltrexone and SSRI antidepressants
Number of subjects: 0
Study 11081320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyreosis group
Number of subjects: 24
Study 11081320 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 8994010 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric method for measuring forearm and hand volumes
Number of subjects: 0
Study 8994010 — intervention group
Group type: COMPARATOR
Intervention: Water displacement method
Number of subjects: 0
Study 8309864 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG-CoA reductase inhibitors and gemfibrozil (Lopid)
Number of subjects: 0
Study 8309864 — intervention group
Group type: COMPARATOR
Intervention: Niacin or bile acid-binding resins
Number of subjects: 0
Study 2453766 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth control vaccine (synthetic peptide antigen representing the aminoacid sequence 109‐145 of the C‐terminal region of the beta subunit of human chorionic gonadotropin)
Number of subjects: 30
Study 31781701 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% anorganic bovine bone (ABB) and 50% autogenous bone (group A)
Number of subjects: 32
Study 31781701 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% anorganic bovine bone (group B)
Number of subjects: 32
Study 27967216 — intervention group
Group type: EXPERIMENTAL
Intervention: Externalized ureteral catheter (EUC)
Number of subjects: 109
Study 27967216 — intervention group
Group type: COMPARATOR
Intervention: Double-J ureteral stent (DJ)
Number of subjects: 109
Study 25873214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink-veneered zirconia abutments (test)
Number of subjects: 20
Study 25873214 — intervention group
Group type: COMPARATOR
Intervention: Non-veneered zirconia abutments (control)
Number of subjects: 20
Study 22782995 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline 10 ml/kg
Number of subjects: 50
Study 22782995 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine 2.5-5 mcg/kg per min
Number of subjects: 50
Study 22782995 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 50
Study 21291445 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 891
Study 21291445 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 891
Study 19278381 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective breastfeeding technique (observed by health visitors)
Number of subjects: 570
Study 19278381 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier use
Number of subjects: 570
Study 19278381 — intervention group
Group type: EXPERIMENTAL
Intervention: Single correction of breastfeeding technique
Number of subjects: 570
Study 16904519 — intervention group
Group type: EXPERIMENTAL
Intervention: AF+C (Accelerated Fractionation with Concurrent Chemotherapy)
Number of subjects: 189
Study 16904519 — intervention group
Group type: COMPARATOR
Intervention: CF+C (Conventional Fractionation with Concurrent Chemotherapy)
Number of subjects: 189
Study 16904519 — intervention group
Group type: COMPARATOR
Intervention: AF (Accelerated Fractionation)
Number of subjects: 189
Study 16904519 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CRT arms (Concurrent Chemoradiotherapy)
Number of subjects: 189
Study 14634826 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic athletes during exercise (running)
Number of subjects: 20
Study 14634826 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic athletes during exercise (cycling)
Number of subjects: 20
Study 14634826 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic athletes during exercise (cycling)
Number of subjects: 20
Study 14634826 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic athletes at rest
Number of subjects: 20
Study 11727017 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatbed scanner
Number of subjects: 40
Study 11727017 — intervention group
Group type: EXPERIMENTAL
Intervention: Film digitizer
Number of subjects: 40
Study 11727017 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital camera
Number of subjects: 40
Study 11727017 — intervention group
Group type: COMPARATOR
Intervention: Hard copy images
Number of subjects: 40
Study 11727017 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall image quality
Number of subjects: 40
Study 8873700 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine mesylate (12.5 mg/day for 28 days)
Number of subjects: 5
Study 8873700 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 weeks)
Number of subjects: 5
Study 8873700 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 5
Study 8873700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 8873700 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine responders
Number of subjects: 5
Study 1676367 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (100 mg)
Number of subjects: 8
Study 1676367 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg)
Number of subjects: 8
Study 1676367 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fenoldopam and enalapril
Number of subjects: 8
Study 1676367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6324161 — intervention group
Group type: EXPERIMENTAL
Intervention: Azlocillin + Amikacin
Number of subjects: 800
Study 6324161 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime + Amikacin
Number of subjects: 800
Study 6324161 — intervention group
Group type: COMPARATOR
Intervention: Ticarcillin + Amikacin
Number of subjects: 800
Study 30856205 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with pictorial representations; three meetings with interactive activities about healthy eating principles, food classification, reading labels, analyzing food advertising, and representations of healthy and unhealthy meals.
Number of subjects: 461
Study 30856205 — intervention group
Group type: COMPARATOR
Intervention: Control group; no exposure to any activity
Number of subjects: 461
Study 30151703 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib for 7 days prior to indicated resection followed by adjuvant palbociclib (Arm 1)
Number of subjects: 22
Study 30151703 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib without resection (Arm 2)
Number of subjects: 22
Study 30151703 — intervention group
Group type: COMPARATOR
Intervention: Palbociclib (both arms)
Number of subjects: 22
Study 26426577 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 0.1% and clonidine 1.5 μg ml⁻¹ (RC1.5 group; n = 65)
Number of subjects: 195
Study 26426577 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 0.1% and clonidine 3 μg ml⁻¹ (RC3 group; n = 65)
Number of subjects: 195
Study 26426577 — intervention group
Group type: COMPARATOR
Intervention: ropivacaine 0.1% and sufentanil 0.25 μg ml⁻¹ (RS group; n = 65)
Number of subjects: 195
Study 26426577 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine groups (RC1.5 and RC3)
Number of subjects: 195
Study 26426577 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3 μg ml⁻¹
Number of subjects: 195
Study 26426577 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 195
Study 22944391 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg/2 mL)
Number of subjects: 80
Study 22944391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pheniramine hydrogen maleate (45.5 mg/2 mL)
Number of subjects: 80
Study 22944391 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (Dexamethasone and Pheniramine)
Number of subjects: 80